GB Sciences Competitors

Innovative Industrial Properties (NYSE:IIPR) and GB Sciences (OTCMKTS:GBLX) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for Innovative Industrial Properties and GB Sciences, as reported by MarketBeat.

Innovative Industrial Properties currently has a consensus price target of $192.4286, suggesting a potential upside of 6.95%. Given Innovative Industrial Properties' higher probable upside, equities analysts plainly believe Innovative Industrial Properties is more favorable than GB Sciences.

Earnings & Valuation

This table compares Innovative Industrial Properties and GB Sciences' revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than GB Sciences.

Insider & Institutional Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Innovative Industrial Properties and GB Sciences' net margins, return on equity and return on assets.

Summary

Innovative Industrial Properties beats GB Sciences on 8 of the 8 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and GB Sciences (OTCMKTS:GBLX) are both basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for GrowGeneration and GB Sciences, as reported by MarketBeat.

GrowGeneration currently has a consensus price target of $49.5714, suggesting a potential upside of 8.21%. Given GrowGeneration's higher probable upside, equities analysts plainly believe GrowGeneration is more favorable than GB Sciences.

Earnings & Valuation

This table compares GrowGeneration and GB Sciences' revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than GB Sciences.

Insider & Institutional Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares GrowGeneration and GB Sciences' net margins, return on equity and return on assets.

Summary

GrowGeneration beats GB Sciences on 8 of the 8 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and GB Sciences (OTCMKTS:GBLX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for 22nd Century Group and GB Sciences, as reported by MarketBeat.

Earnings & Valuation

This table compares 22nd Century Group and GB Sciences' revenue, earnings per share (EPS) and valuation.

Profitability

This table compares 22nd Century Group and GB Sciences' net margins, return on equity and return on assets.

Summary

22nd Century Group beats GB Sciences on 1 of the 1 factors compared between the two stocks.

KushCo (OTCMKTS:KSHB) and GB Sciences (OTCMKTS:GBLX) are both multi-sector conglomerates companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for KushCo and GB Sciences, as reported by MarketBeat.

KushCo currently has a consensus price target of $1.8750, suggesting a potential upside of 75.23%. Given KushCo's higher probable upside, equities analysts plainly believe KushCo is more favorable than GB Sciences.

Earnings & Valuation

This table compares KushCo and GB Sciences' revenue, earnings per share (EPS) and valuation.

GB Sciences has lower revenue, but higher earnings than KushCo.

Insider & Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares KushCo and GB Sciences' net margins, return on equity and return on assets.

Summary

KushCo beats GB Sciences on 5 of the 8 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and GB Sciences (OTCMKTS:GBLX) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for NSAV and GB Sciences, as reported by MarketBeat.com.

Earnings and Valuation

This table compares NSAV and GB Sciences' top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares NSAV and GB Sciences' net margins, return on equity and return on assets.

Terra Tech (OTCMKTS:TRTC) and GB Sciences (OTCMKTS:GBLX) are both industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for Terra Tech and GB Sciences, as reported by MarketBeat.com.

Earnings and Valuation

This table compares Terra Tech and GB Sciences' top-line revenue, earnings per share (EPS) and valuation.

GB Sciences has lower revenue, but higher earnings than Terra Tech.

Institutional & Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Terra Tech and GB Sciences' net margins, return on equity and return on assets.